R&D to Revenue (TTM) Chart

View R&D to Revenue (TTM) for NVDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical R&D to Revenue (TTM) Data

View and export this data back to 2000. Upgrade now.
Date Value
October 31, 2024 --
July 31, 2024 --
April 30, 2024 --
January 31, 2024 --
October 31, 2023 --
July 31, 2023 --
April 30, 2023 --
January 31, 2023 --
October 31, 2022 --
July 31, 2022 --
April 30, 2022 --
January 31, 2022 --
October 31, 2021 --
July 31, 2021 --
April 30, 2021 --
January 31, 2021 --
October 31, 2020 --
July 31, 2020 --
April 30, 2020 --
January 31, 2020 --
October 31, 2019 --
July 31, 2019 --
April 30, 2019 --
January 31, 2019 --
October 31, 2018 --
Date Value
July 31, 2018 --
April 30, 2018 --
January 31, 2018 --
October 31, 2017 --
July 31, 2017 --
April 30, 2017 --
January 31, 2017 --
October 31, 2016 --
July 31, 2016 --
April 30, 2016 --
January 31, 2016 --
October 31, 2015 --
July 31, 2015 --
April 30, 2015 --
January 31, 2015 --
October 31, 2014 --
July 31, 2014 --
April 30, 2014 --
January 31, 2014 --
October 31, 2013 --
July 31, 2013 --
April 30, 2013 --
January 31, 2013 --
October 31, 2012 --
July 31, 2012 --

R&D to Revenue Definition

The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.

Read full definition.

R&D to Revenue (TTM) Range, Past 5 Years

Minimum
Oct 2024
Maximum
Apr 2023
Average
Median